Cargando…

Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial

BACKGROUND: The effects of regional histopathologic changes on prostate MRI scans have not been accurately quantified in men with an elevated prostate-specific antigen (PSA) level and no previous biopsy. PURPOSE: To assess how Gleason grade, maximum cancer core length (MCCL), inflammation, prostatic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stavrinides, Vasilis, Norris, Joseph M., Karapanagiotis, Solon, Giganti, Francesco, Grey, Alistair, Trahearn, Nick, Freeman, Alex, Haider, Aiman, Echeverría, Lina María Carmona, Bott, Simon R. J., Brown, Louise C., Burns-Cox, Nicholas, Dudderidge, Timothy J., Bosaily, Ahmed El-Shater, Ghei, Maneesh, Henderson, Alastair, Hindley, Richard G., Kaplan, Richard S., Oldroyd, Robert, Parker, Chris, Persad, Raj, Rosario, Derek J., Shergill, Iqbal S., Winkler, Mathias, Kirkham, Alex, Punwani, Shonit, Whitaker, Hayley C., Ahmed, Hashim U., Emberton, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614676/ https://www.ncbi.nlm.nih.gov/pubmed/36511804 http://dx.doi.org/10.1148/radiol.220762

Ejemplares similares

What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort
por: Norris, Joseph M., et al.
Publicado: (2020)

False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS [Image: see text] ()
por: Stavrinides, Vasilis, et al.
Publicado: (2021)

A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists
por: Carmona Echeverria, Lina Maria, et al.
Publicado: (2020)

The University College London/Medical Research Council/National Institute of Health Research-Health Technology Assessment PROMIS Trial: An Update
por: El-Shater Bosaily, Ahmed, et al.
Publicado: (2015)

Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?
por: Giganti, Francesco, et al.
Publicado: (2022)

PROMIS — Prostate MR imaging study: A paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer()
por: El-Shater Bosaily, A., et al.
Publicado: (2015)

The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial
por: El-Shater Bosaily, A, et al.
Publicado: (2016)

Erratum: The concordance between the volume hotspot and the grade hotspot: a 3-D reconstructive model using the pathology outputs from the PROMIS trial
por: El-Shater Bosaily, A, et al.
Publicado: (2016)

Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study [Image: see text] ()
por: Stavrinides, Vasilis, et al.
Publicado: (2020)

Prostate MRI quality: a critical review of the last 5 years and the role of the PI-QUAL score
por: Giganti, Francesco, et al.
Publicado: (2022)

Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort
por: Giganti, Francesco, et al.
Publicado: (2020)

Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial
por: Giganti, Francesco, et al.
Publicado: (2021)

Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study
por: Giganti, Francesco, et al.
Publicado: (2019)

Understanding PI-QUAL for prostate MRI quality: a practical primer for radiologists
por: Giganti, Francesco, et al.
Publicado: (2021)

Defining the level of evidence for technology adoption in the localized prostate cancer pathway
por: Valerio, Massimo, et al.
Publicado: (2014)

Mapping PSA density to outcome of MRI-based active surveillance for prostate cancer through joint longitudinal-survival models
por: Stavrinides, Vasilis, et al.
Publicado: (2021)

Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study
por: Brembilla, Giorgio, et al.
Publicado: (2022)

Exploring Patient Views and Acceptance of Multiparametric Magnetic Resonance Imaging for the Investigation of Suspected Prostate Cancer (the PACT Study): A Mixed-Methods Study Protocol
por: Norris, Joseph M., et al.
Publicado: (2020)

Prostate cancer diagnostic pathway: Is a one-stop cognitive MRI targeted biopsy service a realistic goal in everyday practice? A pilot cohort in a tertiary referral centre in the UK
por: Bass, Edward James, et al.
Publicado: (2018)

Logistic regression model for diagnosis of transition zone prostate cancer on multi-parametric MRI
por: Dikaios, Nikolaos, et al.
Publicado: (2014)

“Textural analysis of multiparametric MRI detects transition zone prostate cancer”
por: Sidhu, Harbir S., et al.
Publicado: (2016)

Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study
por: Ahmed, Hashim U, et al.
Publicado: (2012)

Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway()
por: Dickinson, Louise, et al.
Publicado: (2013)

A multicentre randomised controlled trial assessing whether MRI-targeted biopsy is non-inferior to standard transrectal ultrasound guided biopsy for the diagnosis of clinically significant prostate cancer in men without prior biopsy: a study protocol
por: Kasivisvanathan, Veeru, et al.
Publicado: (2017)

Multi-parametric MRI zone-specific diagnostic model performance compared with experienced radiologists for detection of prostate cancer
por: Dikaios, Nikolaos, et al.
Publicado: (2018)

A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study()()
por: Dickinson, L., et al.
Publicado: (2013)

AutoProstate: Towards Automated Reporting of Prostate MRI for Prostate Cancer Assessment Using Deep Learning
por: Mehta, Pritesh, et al.
Publicado: (2021)

Which Prostate Cancers are Undetected by Multiparametric Magnetic Resonance Imaging in Men with Previous Prostate Biopsy? An Analysis from the PICTURE Study
por: Norris, Joseph M., et al.
Publicado: (2021)

Optimising the Diagnosis of Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging: A Cost-effectiveness Analysis Based on the Prostate MR Imaging Study (PROMIS)
por: Faria, Rita, et al.
Publicado: (2018)

Relationship of prostate cancer topography and tumour conspicuity on multiparametric magnetic resonance imaging: a protocol for a systematic review and meta-analysis
por: Satish, Pranav, et al.
Publicado: (2022)

Focal HIFU therapy for anterior compared to posterior prostate cancer lesions
por: Huber, Philipp M., et al.
Publicado: (2020)

MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial
por: Giganti, Francesco, et al.
Publicado: (2017)

The PROMIS of QALYs
por: Hanmer, Janel, et al.
Publicado: (2015)

A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer
por: Guillaumier, Stephanie, et al.
Publicado: (2018)

High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series
por: Ahmed, H U, et al.
Publicado: (2009)

Simplified Luminal Water Imaging for the Detection of Prostate Cancer From Multiecho T(2) MR Images
por: Devine, William, et al.
Publicado: (2018)

The ReIMAGINE Multimodal Warehouse: Using Artificial Intelligence for Accurate Risk Stratification of Prostate Cancer
por: Santaolalla, Aida, et al.
Publicado: (2021)

Standardisation of prostate multiparametric MRI across a hospital network: a London experience
por: Papoutsaki, Marianthi-Vasiliki, et al.
Publicado: (2021)

Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol
por: Asif, Aqua, et al.
Publicado: (2023)

Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer
por: Elliott, Daisy, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5imsgu678328tugi63c4nne704